| Financial Year |
March 31 2023 |
| Monetary Funds |
7,576,804,663.79 |
| Held-for-trading Financial Assets |
15,835,899,595.17 |
| Notes Receivable |
-- |
| Accounts Receivable |
48,337,588.58 |
| Advances to Suppliers |
14,605,078.19 |
| Other Receivables |
22,559,955.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
142,401.49 |
| Inventories |
658,776.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
212,914,075.11 |
| Other Current Assets |
6,858,468,663.68 |
| Total Current Assets |
36,648,305,248.47 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
118,498,758.77 |
| Investment Properties |
3,708,771.53 |
| Fixed Assetes |
125,216,341.07 |
| Under-construction Projects |
39,619,752.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
157,987,496.12 |
| R&D expenses |
5,041,519.59 |
| Goodwill |
58,467,033.18 |
| Long-Term Deferred and Prepaid Expenses |
15,348,287.46 |
| Deferred Income Tax Assets |
135,160,753.51 |
| Other Non-Current Assets |
1,400,000.00 |
| Sub-Total of Non-Current Assets |
2,234,313,219.41 |
| Total Assets |
38,882,618,467.88 |
| Short-Term Loans |
218,412,331.17 |
| Trading Financial liabilities |
472,707,032.42 |
| Notes Payable |
-- |
| Accounts Payable |
60,581,421.15 |
| Accounts Received In Advance |
90,000.00 |
| Employee Compensation Payable |
156,442,123.53 |
| Taxes Payable |
31,946,839.04 |
| Interest Payable |
-- |
| Dividend Payable |
687,056.62 |
| Other payables |
107,352,975.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,163,218,502.86 |
| Other Current Liabilities |
3,682,943,184.22 |
| Sub-Total of Current Liabilities |
26,452,441,379.69 |
| Long-term Loans |
-- |
| Bonds Payable |
3,599,234,113.46 |
| Long-Term Accounts Payable |
1,000,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
98,492,437.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,790,009,729.34 |
| Total Liabilities |
31,242,451,109.03 |
| Paid-In Capital(Or Share Stock) |
1,060,899,292.00 |
| Capital Surplus |
1,841,256,779.11 |
| Surplus Reserve |
371,822,011.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,314,739,326.12 |
| Minority Stockholder's Interest |
120,803,254.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,519,364,104.58 |
| Owner's Equity（Stockholder's Equity） |
7,640,167,358.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,882,618,467.88 |
